SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001654954-17-000710
Filing Date
2017-02-02
Accepted
2017-02-02 16:21:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G mbrauser13g_mabvaxjan2017.htm SC 13G 59914
  Complete submission text file 0001654954-17-000710.txt   61285
Mailing Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121
Business Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Subject) CIK: 0001109196 (see all company filings)

IRS No.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-60385 | Film No.: 17568537
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4400 BISCAYNE BLVD. SUITE 850 MIAMI FL 33137
Business Address
Brauser Michael (Filed by) CIK: 0001336508 (see all company filings)

Type: SC 13G